Ebola Virus Transmission Initiated by Relapse of Systemic Ebola Virus Disease

During the 2018-2020 Ebola virus disease (EVD) outbreak in North Kivu province in the Democratic Republic of Congo, EVD was diagnosed in a patient who had received the recombinant vesicular stomatitis virus-based vaccine expressing a ZEBOV glycoprotein (rVSV-ZEBOV) (Merck). His treatment included an Ebola virus (EBOV)-specific monoclonal antibody (mAb114), and he recovered within 14 days. However, 6 months later, he presented again with severe EVD-like illness and EBOV viremia, and he died. We initiated epidemiologic and genomic investigations that showed that the patient had had a relapse of acute EVD that led to a transmission chain resulting in 91 cases across six health zones over 4 months. (Funded by the Bill and Melinda Gates Foundation and others.) In this report from the Democratic Republic of Congo, Ebola virus disease (EVD) developed in a young man, and he recovered after treatment with a monoclonal antibody. Six months later, EVD recrudesced, and he transmitted the virus to others and died from EVD.

Automated summary

During the Ebola virus disease outbreak in the Democratic Republic of Congo, a young man developed EVD, recovered after receiving monoclonal antibody treatment, but later experienced a relapse, transmitted the virus, and ultimately died.